Evaluation of Podoplanin in Oral Leukoplakia and Oral Squamous Cell Carcinoma
Background. Recent studies have demonstrated that podoplanin was expressed in some dysplastic lesions adjacent to primary oral cancers suggesting that podoplanin expression may occur in early oral tumorigenesis and lymphangiogenesis and therefore is related to tumor growth. The purpose of this study...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2015-01-01
|
| Series: | Scientifica |
| Online Access: | http://dx.doi.org/10.1155/2015/135298 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832563792741924864 |
|---|---|
| author | Ashok Patil Kishor Patil Suyog Tupsakhare Mahesh Gabhane Shrikant Sonune Shilpa Kandalgaonkar |
| author_facet | Ashok Patil Kishor Patil Suyog Tupsakhare Mahesh Gabhane Shrikant Sonune Shilpa Kandalgaonkar |
| author_sort | Ashok Patil |
| collection | DOAJ |
| description | Background. Recent studies have demonstrated that podoplanin was expressed in some dysplastic lesions adjacent to primary oral cancers suggesting that podoplanin expression may occur in early oral tumorigenesis and lymphangiogenesis and therefore is related to tumor growth. The purpose of this study is to determine the role of podoplanin as a biomarker for cancer risk assessment in oral leukoplakia and correlation of podoplanin expression with grades of oral squamous cell carcinoma (OSCC). Materials and Methods. In the present retrospective study, podoplanin expression was investigated immunohistochemically in 40 patients each of oral leukoplakia and OSCC. The scores were analyzed statistically using one-way ANOVA test followed by Tukey HSD. Results. By applying one-way ANOVA test, there was a highly significant increase of the podoplanin expression from mild to severe dysplasia and from well to poorly differentiated OSCC (P<0.01). Statistically highly significant difference was present between scores of mild to moderate dysplasia, moderate to severe dysplasia, well to poorly differentiated OSCC, and moderately to poorly differentiated OSCC (Tukey HSD test, P<0.01). Conclusion. Podoplanin can be used as a biomarker for early oral tumorigenesis and for malignant transformation risk assessment of premalignant lesions and as a tumor progression biomarker for advanced grades of OSCC. |
| format | Article |
| id | doaj-art-8f89b1350342461c8ecfdf744c30120c |
| institution | Kabale University |
| issn | 2090-908X |
| language | English |
| publishDate | 2015-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Scientifica |
| spelling | doaj-art-8f89b1350342461c8ecfdf744c30120c2025-02-03T01:12:32ZengWileyScientifica2090-908X2015-01-01201510.1155/2015/135298135298Evaluation of Podoplanin in Oral Leukoplakia and Oral Squamous Cell CarcinomaAshok Patil0Kishor Patil1Suyog Tupsakhare2Mahesh Gabhane3Shrikant Sonune4Shilpa Kandalgaonkar5Department of Oral Pathology and Microbiology, SMBT Dental College and Hospital, Sangamner, Maharashtra 422608, IndiaDepartment of Oral Pathology and Microbiology, SMBT Dental College and Hospital, Sangamner, Maharashtra 422608, IndiaDepartment of Oral Pathology and Microbiology, SMBT Dental College and Hospital, Sangamner, Maharashtra 422608, IndiaDepartment of Oral Pathology and Microbiology, SMBT Dental College and Hospital, Sangamner, Maharashtra 422608, IndiaDepartment of Oral Pathology and Microbiology, SMBT Dental College and Hospital, Sangamner, Maharashtra 422608, IndiaDepartment of Oral Pathology and Microbiology, SMBT Dental College and Hospital, Sangamner, Maharashtra 422608, IndiaBackground. Recent studies have demonstrated that podoplanin was expressed in some dysplastic lesions adjacent to primary oral cancers suggesting that podoplanin expression may occur in early oral tumorigenesis and lymphangiogenesis and therefore is related to tumor growth. The purpose of this study is to determine the role of podoplanin as a biomarker for cancer risk assessment in oral leukoplakia and correlation of podoplanin expression with grades of oral squamous cell carcinoma (OSCC). Materials and Methods. In the present retrospective study, podoplanin expression was investigated immunohistochemically in 40 patients each of oral leukoplakia and OSCC. The scores were analyzed statistically using one-way ANOVA test followed by Tukey HSD. Results. By applying one-way ANOVA test, there was a highly significant increase of the podoplanin expression from mild to severe dysplasia and from well to poorly differentiated OSCC (P<0.01). Statistically highly significant difference was present between scores of mild to moderate dysplasia, moderate to severe dysplasia, well to poorly differentiated OSCC, and moderately to poorly differentiated OSCC (Tukey HSD test, P<0.01). Conclusion. Podoplanin can be used as a biomarker for early oral tumorigenesis and for malignant transformation risk assessment of premalignant lesions and as a tumor progression biomarker for advanced grades of OSCC.http://dx.doi.org/10.1155/2015/135298 |
| spellingShingle | Ashok Patil Kishor Patil Suyog Tupsakhare Mahesh Gabhane Shrikant Sonune Shilpa Kandalgaonkar Evaluation of Podoplanin in Oral Leukoplakia and Oral Squamous Cell Carcinoma Scientifica |
| title | Evaluation of Podoplanin in Oral Leukoplakia and Oral Squamous Cell Carcinoma |
| title_full | Evaluation of Podoplanin in Oral Leukoplakia and Oral Squamous Cell Carcinoma |
| title_fullStr | Evaluation of Podoplanin in Oral Leukoplakia and Oral Squamous Cell Carcinoma |
| title_full_unstemmed | Evaluation of Podoplanin in Oral Leukoplakia and Oral Squamous Cell Carcinoma |
| title_short | Evaluation of Podoplanin in Oral Leukoplakia and Oral Squamous Cell Carcinoma |
| title_sort | evaluation of podoplanin in oral leukoplakia and oral squamous cell carcinoma |
| url | http://dx.doi.org/10.1155/2015/135298 |
| work_keys_str_mv | AT ashokpatil evaluationofpodoplanininoralleukoplakiaandoralsquamouscellcarcinoma AT kishorpatil evaluationofpodoplanininoralleukoplakiaandoralsquamouscellcarcinoma AT suyogtupsakhare evaluationofpodoplanininoralleukoplakiaandoralsquamouscellcarcinoma AT maheshgabhane evaluationofpodoplanininoralleukoplakiaandoralsquamouscellcarcinoma AT shrikantsonune evaluationofpodoplanininoralleukoplakiaandoralsquamouscellcarcinoma AT shilpakandalgaonkar evaluationofpodoplanininoralleukoplakiaandoralsquamouscellcarcinoma |